Thrombolysis will continue to be the mainstay for acute stroke treatment, despite the recent revolution in neurointerventional clot retrieval. However, as there are ongoing limitations of thrombolysis of bleeding risk and reduced efficacy in large clots – what possible therapeutic advancements can complement or act as an adjuvant to thrombolysis? Neurointervention – effective, but limited […]
了解更多
For over 30 years, India has been conducting global clinical trials. With over 500 sites and over a billion people, India was a key destination for clinical trials for its vast treatment naïve clinical population. However, the environment has fluctuated throughout recent years, as The Central Drugs Standard Control Organization (CDSCO), India’s regulatory agency for […]
了解更多
Developing nations suffer acutely from health epidemics due to lack of resources to adequately combat these epidemics. Many of these epidemics are managed reasonable well in developed nations but with low socioeconomic levels and poor living conditions, coupled with weak health infrastructure, diseases such as enteric and diarrheal diseases and AIDS are still major killers […]
了解更多
New initiatives from the country’s regulator aim to smooth the registration of trials and ensure prospective participants fully understand what will be involved through mandatory AV recording of the consent process. Clinical trial applications in India are taking a step forward, with the approval of a Central Drugs Standard Control Organisation (CDSCO) IT-enabled system from […]
了解更多
Effective 2nd August 2016, the Central Drugs Standard Control Organization (CDSCO) India released new circulars in relation to the conduct of clinical trials. These new circulars have modified […]
了解更多
On a global scale, rotavirus causes over 500,000 deaths in children per year, particularly in emerging countries. Rotavirus is a contagious virus that can cause inflammation of the stomach and […]
了解更多
Effective 2nd August 2016, the Central Drugs Standard Control Organization (CDSCO) India released new circulars in relation to the conduct of clinical trials. These new circulars have modified […]
了解更多
The Central Drugs Standard Control Organization (CDSCO), India’s regulatory agency for clinical research, has made a series of announcements and corrections
了解更多
In order to meet the growing needs of our customers, 乔治临床( George Clinical ) has expanded its geographical footprint within Asia. In 2012 we saw the opening of a second 乔治临床( George Clinical ) […]
了解更多
